Grifols HyperRAB(R) (rabies immune globulin [human]) 300 IU/mL Receives FDA Approval to Treat Patients Exposed to Rabies Virus Infection

Innovative new formulation delivers higher concentration of anti-rabies virus antibodies per mL at wound site compared to other rabies immune globulin products on the market Reduced volume of medication offers potential for fewer injections for patients... Biopharmaceuticals, FDA Grifols, HyperRAB, rabies immune globulin, Rabies Virus
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news